Silymarin for the prevention of contrast-induced nephropathy: A placebo-controlled clinical trial

Background: Silymarin is a flavonoid complex with nephro-protective properties. We evaluated the efficacy of silymarin in the prevention of contrast-induced nephropathy (CIN). Methods: This placebo-controlled clinical trial was conducted on 143 patients with chronic stable angina referring for elec...

Full description

Bibliographic Details
Main Authors: Zohreh Sedighifard, Farshad Roghani, Peyman Bidram, Samaneh Aalami Harandi, Safieh Molavi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:International Journal of Preventive Medicine
Subjects:
Online Access:http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2016;volume=7;issue=1;spage=23;epage=23;aulast=Sedighifard